Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MAP3K11/GDF15 axis is a critical driver of cancer cachexia
Lorena Lerner, Julie Tao, Qing Liu, et al.
Journal of Cachexia Sarcopenia and Muscle (2015) Vol. 7, Iss. 4, pp. 467-482
Open Access | Times Cited: 149

Showing 26-50 of 149 citing articles:

Muscle Wasting Diseases: Novel Targets and Treatments
Regula Furrer, Christoph Handschin
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 315-339
Open Access | Times Cited: 86
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions
Jawed A. Siddiqui, Ramesh Pothuraju, Maneesh Jain, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 2, pp. 188359-188359
Open Access | Times Cited: 83
Mitochondria, immunosenescence and inflammaging: a role for mitokines?
Maria Conte, Morena Martucci, Antonio Chiariello, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 5, pp. 607-617
Open Access | Times Cited: 78
Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
Adeline Dolly, Jean‐François Dumas, Stéphane Servais
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 6, pp. 1413-1428
Open Access | Times Cited: 72
Emerging signaling mediators in the anorexia–cachexia syndrome of cancer
Erin E. Talbert, Denis C. Guttridge
Trends in cancer (2022) Vol. 8, Iss. 5, pp. 397-403
Open Access | Times Cited: 44
Emerging Progress in Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum: Challenges and Opportunities
Chuan Liu, Zhao Guo, Danni Qiao, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 43
GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway
Wanli Zhang, Weikuan Sun, Xiaofan Gu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 42
Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
André Lima Queiroz, Ezequiel Dantas, Shakti Ramsamooj, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Molecular Mechanisms of Cachexia: A Review
Mahdi Neshan, Diamantis I. Tsilimigras, Xu Han, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 252-252
Open Access | Times Cited: 15
Area postrema neurons mediate interleukin-6 function in cancer cachexia
Qingtao Sun, Daniëlle van de Lisdonk, Miriam Ferrer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
Jian Li, Xiangjun Hu, Zichuan Xie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116809-116809
Open Access | Times Cited: 13
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study design
John D. Groarke, Jeffrey Crawford, Susie M. Collins, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 3, pp. 1054-1061
Open Access | Times Cited: 11
Combination of bulk RNA sequencing and scRNA sequencing uncover the molecular characteristics of MAPK signaling in kidney renal clear cell carcinoma
Xiunan Li, Hewen Guan, Chuanyu Ma, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1414-1439
Open Access | Times Cited: 9
The mitochondrial metabolic reprogramming agent trimetazidine as an ‘exercise mimetic’ in cachectic C26‐bearing mice
Francesca Molinari, Fabrizio Pin, Stefania Gorini, et al.
Journal of Cachexia Sarcopenia and Muscle (2017) Vol. 8, Iss. 6, pp. 954-973
Open Access | Times Cited: 80
Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice
Susan C. Kandarian, Rachel L. Nosacka, Andrea E. Delitto, et al.
Journal of Cachexia Sarcopenia and Muscle (2018) Vol. 9, Iss. 6, pp. 1109-1120
Open Access | Times Cited: 78
Barriers to cancer nutrition therapy: excess catabolism of muscle and adipose tissues induced by tumour products and chemotherapy
Dalton Luiz Schiessel, Vickie E. Baracos
Proceedings of The Nutrition Society (2018) Vol. 77, Iss. 4, pp. 394-402
Open Access | Times Cited: 70
The expression landscape of cachexia‐inducing factors in human cancers
Paula Paccielli Freire, Geysson Javier Fernández, Diogo de Moraes, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 4, pp. 947-961
Open Access | Times Cited: 66
GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS
Vicky Wang-Wei Tsai, Hong Ping Zhang, Rakesh Manandhar, et al.
International Journal of Obesity (2019) Vol. 43, Iss. 12, pp. 2370-2380
Closed Access | Times Cited: 62
Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality
Marlena S. Fejzo, Peter A. Fasching, Michael Schneider, et al.
Geburtshilfe und Frauenheilkunde (2019) Vol. 79, Iss. 04, pp. 382-388
Open Access | Times Cited: 57
GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH
Kook Hwan Kim, Myung‐Shik Lee
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1865, Iss. 3, pp. 129834-129834
Closed Access | Times Cited: 53
Whole‐exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum
Marlena S. Fejzo, Kimber MacGibbon, Olivia First, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2022) Vol. 129, Iss. 11, pp. 1845-1852
Open Access | Times Cited: 32
Role of growth differentiation factor 15 in cancer cachexia (Review)
Tingting Ling, Jing Zhang, Fuwan Ding, et al.
Oncology Letters (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 21
A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia
Jeffrey Crawford, Roberto A. Calle, Susie M. Collins, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 3, pp. 489-497
Open Access | Times Cited: 21
The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative review
Satomi Morita-Tanaka, Tadaaki Yamada, Koichi Takayama
Translational Lung Cancer Research (2023) Vol. 12, Iss. 1, pp. 168-180
Open Access | Times Cited: 19
Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration
Margaret A. Park, Christopher J. Whelan, Sabeen Ahmed, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2364-2364
Open Access | Times Cited: 6

Scroll to top